AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 262: E651-E657, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohara, K.
Right arrow Articles by Milsted, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohara, K.
Right arrow Articles by Milsted, A.

AJP - Endocrinology and Metabolism, Vol 262, Issue 5 E651-E657, Copyright © 1992 by American Physiological Society


ARTICLES

Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system

K. Kohara, K. B. Brosnihan, C. M. Ferrario and A. Milsted
Department of Brain and Vascular Research, Cleveland Clinic Foundation, Ohio 44195.

We investigated whether angiotensin (ANG) II has the potential to regulate expression of genes of the renin-angiotensin system (RAS) in peripheral and central tissues. ANG II (0.1 or 6.0 nmol/h) was infused by osmotic minipump into male Sprague-Dawley rats (225-250 g) for 5 days, either intravenously or intracerebroventricularly. We measured angiotensinogen mRNA in liver, adrenal glands, and brain (hypothalamus and lower brain stem), renin mRNA in the kidney, and angiotensin-converting enzyme (ACE) mRNA in the lung and testis by Northern blot analysis. We demonstrated that plasma ANG II increases the levels of liver angiotensinogen mRNA, decreases kidney renin mRNA, and decreases lung ACE mRNA. Intracerebroventricular administration of ANG II resulted in a different pattern of responses of the peripheral RAS components. Liver angiotensinogen mRNA was increased, and kidney renin mRNA was decreased by both doses of ANG II, whereas lung ACE mRNA remained unresponsive at either dose. Centrally mediated influences of ANG II are most likely indirect since plasma ANG II concentration was not changed. This study has revealed that ANG II has profound diverse effects that influence the regulation of its formation. Further, results indicate that genes of the RAS responded to exogenous ANG II in both tissue- and route-specific ways.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Nishimura, K. Ohtsuka, N. Iwai, H. Takahashi, and M. Yoshimura
Regulation of brain renin-angiotensin system by benzamil-blockable sodium channels
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1416 - R1424.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al.
Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells
J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Tamura, S. Umemura, Y. Sumida, N. Nyui, S.-i. Kobayashi, T. Ishigami, M. Kihara, T. Sugaya, A. Fukamizu, H. Miyazaki, et al.
Effect of Genetic Deficiency of Angiotensinogen on the Renin-Angiotensin System
Hypertension, August 1, 1998; 32(2): 223 - 227.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Costerousse, J. Allegrini, J.-P. Clozel, J. Ménard, and F. Alhenc-Gelas
Angiotensin I-Converting Enzyme Inhibition but Not Angiotensin II Suppression Alters Angiotensin I-Converting Enzyme Gene Expression in Vessels and Epithelia
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1180 - 1187.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. J. Rieder, R. J. Roman, and A. S. Greene
Reversal of Microvascular Rarefaction and Reduced Renal Mass Hypertension
Hypertension, July 1, 1997; 30(1): 120 - 127.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Milsted, M. Nishimura, K. B. Brosnihan, and C. M. Ferrario
Differential Regulation of Angiotensinogen Transcripts After Renin Infusion
Hypertension, October 1, 1996; 28(4): 678 - 681.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. R. Brasier and J. Li
Mechanisms for Inducible Control of Angiotensinogen Gene Transcription
Hypertension, March 1, 1996; 27(3): 465 - 475.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online